{"id":"W4386331411","doi":"10.1016/s2152-2650(23)01443-x","title":"MM-364 Elranatamab, a B-Cell Maturation Antigen (BCMA)-CD3 Bispecific Antibody, for Patients With Relapsed/Refractory Multiple Myeloma (RRMM): Extended Follow-Up and Biweekly Administration From the MagnetisMM-3 Study","year":2023,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Medicine; Multiple myeloma; Antibody; Antigen; Bispecific antibody; CD3; Immunology; Cancer research; Monoclonal antibody; CD8","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002067353,0.0006347616,0.001352398,0.0003570036,0.0004294411,0.0008789003,0.0006015137,0.0007705758,0.001092188],"category_scores_gemma":[0.0008982085,0.0002907241,0.001393016,0.0005215869,0.0003957017,0.0007591517,0.0004086375,0.001433547,0.000353443],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001063473,"about_ca_system_score_gemma":0.0008260231,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001891855,"about_ca_topic_score_gemma":0.004044736,"domain_scores_codex":[0.9994187,0.0002443883,0.00003844131,0.00008813077,0.00007890836,0.0001314142],"domain_scores_gemma":[0.9994374,0.0001083136,0.0001218224,0.00007180288,0.00004037506,0.0002203473],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.5276278,0.008915345,0.1379235,0.0007518705,0.004281115,0.0007967179,0.0003606511,0.00197971,0.02830278,0.0002502467,0.004749984,0.2840604],"study_design_scores_gemma":[0.1523378,0.1744027,0.6379139,0.000176896,0.005615256,0.001224057,0.0002151791,0.002071939,0.007361266,0.0006345859,0.01793813,0.0001082484],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9921585,0.004776385,0.000271033,0.0004242328,0.00005002578,0.0001961933,0.0009602641,0.00003434044,0.001128874],"genre_scores_gemma":[0.9946756,0.001219376,0.0004270319,0.0006218761,0.00007645652,0.0001444072,0.00208713,0.00001041508,0.0007376259],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002067353,"threshold_uncertainty_score":0.01093334,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03424286184106232,"score_gpt":0.3329608377631547,"score_spread":0.2987179759220924,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}